Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for INLIF Limited (INLF : NSDQ)

• Company Description    INLIF LIMITED is a company engaged in the research, development, manufacturing and sales of injection molding machine-dedicated manipulator arms. INLIF LIMITED is based in Quanzhou, China. Number of Employees: 15

• Price / Volume Information    Yesterday's Closing Price: $0.48 Daily Weekly Monthly 20 Day Moving Average: 78,745 shares Shares Outstanding: 14.50 (millions) Market Capitalization: $6.98 (millions) Beta: 52 Week High: $10.00 52 Week Low: $0.46 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -27.78% -27.66% 12 Week -34.65% -35.70% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL No. 88 Hongsi RoadYangxi New Area Honglai Town - Quanzhou,F4 00000 CHN ph: 86-153-7576-0760 fax: - None http://www.yiwate88.com

• General Corporate Information    Officers Rongjun Xu - Chief Executive Officer Wenzao Huang - Chairman Yanting Chen - Chief Financial Officer Yunjun Huang - Director Yaner Zhang - Director Peer Information INLIF Limited (BJCT) INLIF Limited (CADMQ) INLIF Limited (APNO) INLIF Limited (UPDC) INLIF Limited (IMTIQ) INLIF Limited (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: G4808M100 SIC: 3569 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: 05/05/26 Share - Related Items Shares Outstanding: 14.50 Most Recent Split Date: (:1) Beta: Market Capitalization: $6.98 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/05/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.44 Price/Cash Flow: 3.57 Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 12/31/25 - - 09/30/25 - - 06/30/25 - - ROA 12/31/25 - - 09/30/25 - - 06/30/25 - - Current Ratio 12/31/25 - - 09/30/25 - - 06/30/25 - 2.43 Quick Ratio 12/31/25 - - 09/30/25 - - 06/30/25 - 1.91 Operating Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Net Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Pre-Tax Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Book Value 12/31/25 - - 09/30/25 - - 06/30/25 - 1.09 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - - 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - - 06/30/25 - 0.27

Powered by Zacks Investment Research ©